Treatment and follow-up of low-risk patients with thyroid cancer

被引：0
作者：
Martin Schlumberger
Isabelle Borget
Camila Nascimento
Maryse Brassard
Sophie Leboulleux
机构：
[1] Institut Gustave Roussy and University Paris-Sud,Department of Nuclear Medicine and Endocrine Oncology
来源：
Nature Reviews Endocrinology | 2011年 / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This Perspectives re-evaluates the role of radioiodine treatment following surgery in low-risk patients with undetectable serum thyroglobulin levels after TSH stimulation and without evidence of disease. Moreover, the authors discuss the methods used for preparing low-risk patients for the administration of radioiodine after surgery and the activity of radioiodine that should be administered.
引用
收藏
页码：625 / 628
页数：3
相关论文
共 38 条
  • [1] Cooper DS(2009)Revised management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 1167-1214
  • [2] Pacini F(2006)European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium Eur. J. Endocrinol. 154 787-803
  • [3] Smallridge RC(2007)Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH stimulated thyroglobulin in follow-up of thyroid cancer patients J. Clin. Endocrinol. Metab. 92 82-87
  • [4] Schlumberger M(2007)Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients J. Clin. Endocrinol. Metab. 92 2487-2496
  • [5] Iervasi A(2007)Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer Clin. Endocrinol. (Oxf.) 67 434-441
  • [6] Rosario PW(2008)Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays? Clin. Endocrinol. (Oxf.) 68 338-342
  • [7] Purisch S(2010)Serum basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer Thyroid 20 587-595
  • [8] Spencer C(2011)Value of postoperative thyroglobulin and ultrasonography for the indication of ablation and Thyroid 21 49-53
  • [9] Fatemi S(2010)I activity in patients with thyroid cancer and low risk of recurrence J. Clin. Endocrinol. Metab. 95 230-237
  • [10] Singer P(2010)Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients Head Neck 32 689-698
1234